Isoprenaline Hydrochloride Macure

Isoprenaline Hydrochloride, the active ingredient in Isoprenaline Hydrochloride Macure, is a beta-adrenergic agonist presented as a sterile intravenous solution for intravenous use. It is employed to increase heart rate and contractility in bradycardia or heart block and to provide bronchodilation in asthma and bronchospasm in adult patients.

GNH USA supplies Isoprenaline Hydrochloride Macure as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoprenaline Hydrochloride is used in cardiovascular and respiratory conditions where stimulation of beta‑adrenergic receptors is required.

- Bradycardia: raises heart rate to restore adequate cardiac output. - Heart block: improves atrioventricular conduction and stabilises rhythm. - Asthma: induces bronchodilation to relieve airway obstruction. - Bronchospasm: relaxes bronchial smooth muscle, easing breathing difficulty.

Isoprenaline Hydrochloride may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Tachycardia: rapid increase in heart rate. - Palpitations: sensation of irregular or forceful beats. - Headache: mild to moderate intensity. - Tremor: fine shaking of hands or limbs. - Nausea: upset stomach, sometimes with vomiting. - Anxiety: feelings of nervousness or restlessness.

Serious or Rare Side Effects: - Arrhythmias: potentially life‑threatening irregular rhythms. - Myocardial ischemia: reduced blood flow to heart muscle. - Severe hypertension: dangerous elevation of blood pressure. - Pulmonary edema: fluid accumulation in lungs. - Allergic reactions: rash, itching, or anaphylaxis. - Chest pain: acute discomfort possibly indicating cardiac strain.

When using Isoprenaline Hydrochloride, clinicians should observe several safety measures.

- Cardiac monitoring: continuously assess heart rate and rhythm during infusion. - Dose titration: adjust the infusion rate based on clinical response and vital signs. - Contraindications: avoid in patients with severe tachyarrhythmias or uncontrolled hypertension. - Pregnancy considerations: limited data; use only if potential benefit outweighs risk. - Elderly patients: start at lower rates due to increased sensitivity. - Store at ambient temperature: keep below 25°C, protect from moisture and light, and retain in original packaging.

Isoprenaline Hydrochloride can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Beta‑blockers: antagonize the therapeutic effect and may precipitate severe bradycardia. - Digoxin: combined use can increase the risk of arrhythmias. - MAO inhibitors: may potentiate cardiovascular stimulation and cause hypertensive episodes.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance negative inotropic effects. - Antihypertensives: may require dose adjustments to avoid excessive blood pressure changes. - Anesthetic agents: can alter hemodynamic responses during surgery. - Theophylline: additive bronchodilatory effect may increase risk of tachycardia.